Visca D, Mori L, Tsipouri V, et al. AmbOx: A Randomised Controlled, Crossover Trial Evaluating the Effects of Ambulatory Oxygen on Health Status in Patients with Fibrotic Interstitial Lung Disease. ATS 2017, A7603.
Durvalumab plus platinum-etoposide als eerstelijnsbehandeling bij ES-SCLC
mrt 2020 | Longoncologie